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This study evaluated the effect of derriobtusone A, a flavonoid isolated from Lonchocarpus obtusus, on two important pathogenic
bacteria, Staphylococcus aureus and Escherichia coli, as well as its antioxidant activity and toxicity. Planktonic growth assays were
performed, and the inhibition of biofilm formation was evaluated. In addition, antioxidant activity was assessed by DPPH radical
scavenging assay, ferrous ion chelating assay, ferric-reducing antioxidant power assay, and 𝛽-carotene bleaching assay. Toxicity was
evaluated by the brine shrimp lethality test. Results showed that derriobtusone A completely inhibited the planktonic growth of
S. aureus at 250 and 500 𝜇g/mL; however, it did not have the same activity on E. coli. Derriobtusone A reduced the biomass and
colony-forming unit (cfu) of S. aureus biofilm at concentrations of 250 and 500𝜇g/mL. In various concentrations, it reduced the
biofilm biomass of E. coli, and, in all concentrations, it weakly reduced the cfu. Derriobtusone A showed highly efficient antioxidant
ability in scavenging DPPH radical and inhibiting 𝛽-carotene oxidation.The compound showed no lethality toArtemia sp. nauplii.
In conclusion, derriobtusone A may be an effective molecule against S. aureus and its biofilm, as well as a potential antioxidant
compound with no toxicity.
1. Introduction
Biofilm is a complex agglomeration of microbes adhering
to a solid surface and to one another, all encased in a
scaffold of self-produced extracellular polymeric substances
[1]. By the ability to produce such extracellular polymeric
substances, bacteria present in microbial biofilm show a
reduced growth pattern, with up- and downregulation of
specific genes [2]. Physiological and phenotypical adaptations
that result in antimicrobial tolerance have been attributed to
biofilm formation [3]. Biofilm formation is directly related to
various infectious diseases through colonization on medical
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devices [4, 5]. Several pathogenic bacteria are capable of
forming biofilms; among them are Staphylococcus aureus
and Escherichia coli [6, 7]. However, plants are rich in a
wide variety of molecules with antimicrobial properties, such
as secondary metabolites and proteins [8]. In fact, several
studies have reported on the antimicrobial and antibiofilm
activities of plant compounds as alternatives to antibiotic
therapy [9–12].
Furthermore, the antioxidant activities on reactive oxy-
gen species (ROS) and other free radicals have been attributed
to plant molecules, mostly phenolic compounds [13]. A
common denominator of environmental stress is the produc-
tion and accumulation of ROS, such as superoxide anions
(O
2
−), hydrogen peroxide (H
2
O
2
∙), hydroxyl radicals (OH∙),
and singlet oxygen ( 1O
2
) [13]. ROS accumulation leads to
oxidative stress that can damage cellular components, such as
DNA, lipids, proteins, and sugars [14, 15]. Moreover, ROS are
associated with toxic effects and pathologies such as cancers,
cardiovascular and neurological diseases, and infections [16].
In this context, the use of antioxidant compounds with
the aim of increasing the degradation of ROS and thereby
reducing ROS-associated diseases has been studied [17].
Some studies have reported that plants of the genus Lon-
chocarpus are able to produce compounds, such as alkaloids
and triterpenoids, derived from benzoic acids and flavonoids
[18–22]. Lonchocarpus is a genus of the family Leguminosae,
subfamily Papilionoideae, and it is prevalent in tropical and
subtropical regions, including Brazil [20, 22].
Flavonoids are phenolic compounds consisting of two
benzene rings linked through a heterocyclic pyrimidine ring
[23]. Moreover, flavonoids have been reported to possess
many useful properties, such as anti-inflammatory, antialler-
gic, antitumor, antioxidant, and antimicrobial activities [24–
29]. Aurone constitutes a subclass of flavonoids consisting
of a benzofuranone ring linked through a carbon-carbon
double bond to a phenyl moiety [30], and auronol is an
aurone derivative in which the benzylidene unsaturation has
undergone hydration [31].These compounds comprise a very
small group of flavonoids [31, 32].
Derriobtusone A is a methylated auronol with a fairly
rare occurrence (2-Benzoyl-3-methoxybenzo[1,2-b:3,4-
b󸀠]difuran.) [19]. This compound was the first auronol
found in nature and was initially extracted and isolated
from the roots of Lonchocarpus obtusus by Nascimento and
colleagues [19, 20]. Furthermore, derriobtusone A also was
isolated from the roots of Lonchocarpus montanus, being
among the most abundant compounds found in this species
[19]. Over thirty years have passed since derriobtusone A
was identified. However, only few studies have evaluated
the biological activities of this compound. Therefore, the
present study aims to evaluate the antibacterial effects of
derriobtusone A on Staphylococcus aureus and Escherichia
coli. The antioxidant effects and toxicity of this compound
were also demonstrated.
2. Material and Methods
2.1. Plant Material. The roots of Lonchocarpus obtusus were
collected from Meruoca City (Ceara´ State, Brazil). Plant
OCH3
O
O
O
H
H
Figure 1: Chemical structure of derriobtusone A extracted from the
root bark of Lonchocarpus obtusus.
authentication was performed by Professor Afraˆnio Gomes
Fernandes, and a voucher specimen (number 39550) was
deposited at the Herba´rio Prisco Bezerra (EAC) of the
Departamento de Biologia, Universidade Federal do Ceara´.
2.2. Derriobtusone A Isolation. Derriobtusone A was isolated
as described previously by Cavalcante et al. [22]. Dried root
bark (720 g) and wood (750 g) of Lonchocarpus obtusus were
powdered and then extracted at room temperature with n-
hexane (3×2.0 L). During the distillation process, a yellowish
precipitate was filtrated, and the compound derriobtusone A
was purified by crystallization in acetone (Figure 1).
2.3. Microorganisms. In the present study, the microorgan-
isms used in the experiments were Staphylococcus aureus JKD
6008, a Gram-positive bacterium, and Escherichia coli ATCC
47076, a Gram-negative bacterium.
2.4. Culture Conditions. The bacteria were grown in Trypti-
case SoyAgarmedium (TSA; Liofilchem, Italy) and incubated
at 37∘C for 24 h. After growth on the solid medium, an
isolated colony was removed and inoculated into 10mL of
Trypticase Soy Broth (TSB; Liofilchem, Italy) and incubated
for 18 h at 37∘C under constant agitation of 120 rpm. Prior
to use, the cell concentration of each inoculum was adjusted
to 2 × 106 cells/mL using a spectrophotometer (620 nm) and
calibration curves previously determined for each bacterium.
2.5. Planktonic Growth Assay. The effect of derriobtusone
A on planktonic growth of S. aureus and E. coli was deter-
mined by the broth microdilution method. Briefly, in 96-well
polystyrene plates, derriobtusone A was diluted in TSB (with
4 % of dimethyl sulfoxide [DMSO]) in concentrations of 3.9
to 250 𝜇g/mL. The plates were incubated at 37∘C during 24 h
under constant agitation at 120 rpm. Optical density of the
contents of each well was recorded at 640 nm (OD
640
) using
an automated Elisa reader (Synergy TM HT multidetection
microtiter reader), as a measure of microbial growth. Mini-
mum inhibitory concentration (MIC) was established as the
lowest concentration of compound able to inhibit the visible
growth of microorganism after overnight incubation.
2.6. Biofilm Assays. The methodology used to grow biofilms
was based on the microtiter plate test developed by
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Stepanović et al. [33] with some modifications. Sterile 96-
well polypropylene plates were prepared using a procedure
similar to that used for the planktonic growth assays with
the same initial concentration of cells and derriobtusone A.
All plates were incubated on a horizontal shaker (120 rpm)
at 37∘C during 24 h for biofilm development. After biofilm
growth in the presence or absence of derriobtusone A, the
content of each well was removed, and the biofilms were
washed twice with 200𝜇L/well of sterilized water to remove
weakly adherent cells.
2.6.1. Biomass Quantification. Quantification of biofilm
biomass was determined by crystal violet staining. For
fixation of biofilms, 200 𝜇L of 99% methanol (Romil, UK)
was added to each well, and, after 15min, the methanol was
removed and the plates were dried at room temperature.
Then, 200𝜇L of crystal violet stain (Merck, Germany) was
added to each well. After 5min, the excess of crystal violet
was removed, and the plates were washed in water. Finally,
200𝜇L of acetic acid (33%, v/v) (Pronalab, Portugal) was
added to all wells to dissolve the crystal violet staining, and
the absorbance was measured at 570 nm (OD
570
).
2.6.2. Quantification of Colony-Forming Units. After biofilm
formation, 200𝜇L of sterile water was added to each well,
and the plate was placed in an ultrasonic bath (Sonicor
SC-52; Sonicor Instruments, Copiague, NY, USA, operating
at 50 kHz during 6min). Serial decimal dilutions from the
obtained suspension were plated on TSA. The plates were
then incubated for 24 h at 37∘C, and the total number of
colony-forming units (cfu) per unit area (log
10
cfu/cm2) of
microtiter plate well was enumerated.
2.7. Antioxidant Assays
2.7.1. DPPH (1,1-Difenil-2-picrilidrazil) Radical Scavenging
Assay. The DPPH scavenging activity of derriobtusone A
at concentrations from 7.8 to 500𝜇g/mL was measured
according to the method described by Duan et al. [34].
The absorbance of sample, blank sample, and control was
measured at 517 nm, after 30min incubation in the dark
at room temperature, using a Biochrom Asys UVM 340
microplate reader (Cambridge, UK).The sample consisted of
a mixture of 1mLDPPHmethanolic solution (0.16mM) with
1mL of derriobtusone A.The blank sample consisted of 2mL
of derriobtusone A, while the control contained 2mL DPPH
methanolic solution (0.16mM) only. Ascorbic acid was used
as positive control. The percentage of DPPH scavenging
activity was calculated with the following equation:
Scavenging effect (%)
= [1 −
(O.Dsample −O.Dblank)
O.Dcontrol
] × 100%.
(1)
2.7.2. Ferrous Ion Chelating (FIC) Assay. The ferrous ion
chelating (FIC) power of derriobtusone A was determined
with the method described by Wang et al. [35]. Distilled
water, 2mM ferrous chloride (FeCl
2
), and 5mM ferrozine
were added to the compound at concentrations from 7.8 to
500𝜇g/mL. The blank sample and the control were prepared
with distilled water instead of ferrozine and the compound,
respectively. The sample, the blank sample, and the control
were incubated at room temperature for 10min, and the opti-
cal density wasmeasured at 562 nmusing amicroplate reader
(Biochrom Asys UVM 340). Ethylenediamine tetraacetic
acid (EDTA) was used as positive control. FIC activity was
calculated with the following equation:
Ferrous ion chelating activity (%)
=
[O.Dcontrol − (O.Dsample −O.Dblank)]
O.Dcontrol
× 100%.
(2)
2.7.3. Ferric-Reducing Antioxidant Power (FRAP). Ferric-
reducing antioxidant power (FRAP) of derriobtusone A
was determined using the method described by Ganesan
et al. [36]. Initially, 0.2M phosphate buffer (pH 6.6) and
1% potassium ferricyanide were added to the compound at
different concentrations (7.8 to 500𝜇g/mL).The samples were
then incubated at 50∘C for 20min. After cooling at room
temperature, 10% trichloroacetic acid was added. An aliquot
was mixed with distilled water and 0.1% ferric chloride.
Ten minutes later, the optical density was measured at
700 nm using a microplate reader (Biochrom Asys UVM
340). Butylated hydroxyanisole (BHA) was used as positive
control. Greater absorbance indicated greater FRAP.
2.7.4. 𝛽-Carotene Bleaching (BCB) Assay. The coupled oxida-
tion of 𝛽-carotene and linoleic acid was determined with the
method described by Chew et al. [37]. Tween 40 was added
to 𝛽-carotene (100 𝜇g/mL in chloroform) and linoleic acid.
Following evaporation of the chloroform in a rotating evapo-
rator, oxygen-saturated ultrapure water (Milli-Q) was added,
and themixture was shaken until forming an emulsion.Thus,
the final sample was a mixture of emulsion and compound,
while the control consisted of emulsion only. The optical
density was measured at 470 nm using a microplate reader
(Biochrom Asys UVM 340), followed by another 3 hours
of incubation at 50∘C. BHA was used as positive control.
The antioxidant activity was calculated with the following
equation:
Antioxidant activity (%) = (
O.Dfinal
O.Dinitial
) × 100%. (3)
2.8. Artemia Lethality Test. Artemia sp. cysts were hatched
in sterile artificial seawater at 28∘C under constant light and
strong aeration. The cysts were incubated in a polyethylene
cylindroconical tube with 1 g of cysts per liter of artificial
seawater. After a period of 48 h, the nauplii were collected and
used for bioassays.
DerriobtusoneAwas dissolved in artificial seawater (with
4% DMSO) at a concentration of 1mg/mL. The assay was
performed boarding 24-well Linbro plates in which each
well contained 10 Artemia sp. nauplii in a final volume of
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2mL. The compound solution was added to the wells at final
concentrations of 7.8 to 500𝜇g/mL. The experiments were
performed in triplicate, and negative control wells contained
2mL of artificial seawater (with 4% DMSO) with 10 Artemia
sp. nauplii. After 24 and 48 h, the number of dead nauplii in
each well was counted.
2.9. Statistical Analysis. Statistical analyses were performed
by GraphPad Prism version 5.0 from Microsoft Windows.
The data from all the antimicrobial and biofilm assays were
compared using one-way analysis of variance (ANOVA), with
Bonferroni post hoc test. 𝑃 < 0.05 was considered to be
statistically significant.
For antioxidant assays, the percentage values obtained
for DPPH, FIC, and BCB with each concentration were
converted into absolute values, submitted to angular transfor-
mation, and compared with Student’s t-test for independent
data. FRAP values, as obtained for each concentration, were
also analyzed with Student’s t-test for independent data. 𝑃 <
0.05 was considered to be statistically significant.
3. Results
3.1. Effect of Derriobtusone A on Planktonic Growth. The
results showed that derriobtusone A inhibited the planktonic
growth of Staphylococcus aureus at concentrations of 250
(MIC) and 500 𝜇g/mL. When bacteria were treated with
concentrations ranging from 15.5 to 125𝜇g/mL, only a weakly
inhibition was seen (Figure 2(a)). On the other hand, der-
riobtusoneA at concentrations of 250 and 500 𝜇g/mL showed
a weakly inhibition on Escherichia coli planktonic growth
(Figure 2(b)).
3.2. Effect of Derriobtusone A on Biofilm. Figure 3(a) presents
the results of biofilm biomass of Staphylococcus aureus and
Escherichia coli after 24 h of contact with derriobtusone A.
At concentrations of 250 and 500 𝜇g/mL, data showed that
the compound was able to abruptly reduce the biomass of
Staphylococcus aureus and significantly reduce the biomass
of Escherichia coli at concentrations ranging from 15.6 to
250𝜇g/mL.
Figure 3(b) presents mean values and standard devia-
tions of log
10
cfu/cm2 for both Staphylococcus aureus and
Escherichia coli. Similar to the biomass results, derriobtusone
A at concentrations of 250 and 500 𝜇g/mL reduced the cfu
in S. aureus biofilm by approximately 2.0 log
10
. Interestingly,
derriobtusone A was able to reduce the cfu in Escherichia coli
biofilm between 0.2 and 0.4 log
10
in all concentrations.
3.3. Antioxidant Activity of Derriobtusone A. Derriobtusone
A antioxidant activity was evaluated by four different meth-
ods: DPPH radical scavenging, FIC, FRAP, and BCB.
In the DPPH assay, the compound was able to scavenge
DPPH radical in all concentrations, performing this activity
between 50 and 60%. Ascorbic acid (positive control) showed
significant difference compared to derriobtusone A in all
concentrations, performing this activity between 70 and 97%
(Figure 4(a)).
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Figure 2: Effect of derriobtusone A on planktonic growth of (a) S.
aureus and (b) E. coli. ∗𝑃 < 0.05 compared to control.
Using the FIC assay, derriobtusone A showed chelating
ability of ferrous ion by approximately 8, 10, 14, 17, 19, 22, and
34% in concentrations of 7.8 to 500𝜇g/mL, respectively, while
the positive control (EDTA) showed significantly greater
activity than the compound. In the higher concentrations,
EDTA showed approximately 100% activity (Figure 4(b)).
Derriobtusone A was evaluated by ferric
reducing/antioxidant power assay to determine its ability
to reduce Fe3+ to Fe2+. In this assay, the results showed
that optical density increased weakly with increasing
concentrations of the compound. The variation of optical
density for derriobtusone A ranged from 0.168 to 0.222,
while BHA, the positive control, showed an abrupt increase
of 0.226 to 1.283 in optical density (Figure 4(c)).
The ability of derriobtusone A to inhibit 𝛽-carotene
oxidation was also evaluated. The compound showed a high
antioxidant activity, ranging from 68.7 to 96.5%. Moreover,
the antioxidant activity was similar to positive control in the
higher concentrations (Figure 4(d)).
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Figure 3: Effect of derriobtusone A on biofilm of S. aureus and E.
coli. (a) Biofilm biomass and (b) enumeration of cfu. ∗𝑃 < 0.05
compared to control.
3.4. Toxicity of Derriobtusone A on Artemia sp. The toxicity
of the derriobtusone A on Artemia sp. nauplii was evaluated
after 24 and 48 hours of exposure. Interestingly, the com-
pound showed no lethality to Artemia sp. nauplii at any of
the concentrations tested (data not shown).
4. Discussion
Staphylococcus aureus and Escherichia coli are two microor-
ganisms generally associatedwith human infections, and they
exhibit considerable antimicrobial resistance based on the
ability to form biofilms [6, 7, 38, 39]. This study evaluated
the effect of derriobtusone A, a flavonoid isolated from
Lonchocarpus obtusus, on planktonic growth and biofilm
formation of Staphylococcus aureus and Escherichia coli.
The planktonic growth assay showed that Staphylococcus
aureus was susceptible to the presence of derriobtusone A
in that the molecule totally inhibited bacterial growth at
250𝜇g/mL. On the other hand, Escherichia coli showed more
resistance against the compound.This study corroborated the
findings of Magalha˜es et al. [40] who showed that derriob-
tusone A isolated from Lonchocarpus montanus was activea-
gainst Staphylococcus aureus, but not against Escherichia coli
in a bioautography assay. Other studies have also shown
the antibacterial activity of flavonoids in different concen-
trations [28, 29]. Panduratin A, a chalcone isolated from
Kaempferia pandurata, showed antibacterial action against
clinical Staphylococcus strains in concentrations between
0.063 and 2 𝜇g/mL [41]. Sepicanin A, a flavanone isolated
from Artocarpus sepicanus, inhibited the bacterial growth
of Staphylococcus aureus at 1.2 𝜇g/mL [42]. Furthermore,
the molecule 4󸀠-methoxyflavanone showed action against
Staphylococcus aureus in concentrations up to 1000𝜇g/mL
[43].
The differences in antibacterial activity of flavonoids
at various concentrations have also been investigated. For
example, according to Basile and coworkers [44], apigenin,
a flavanone isolated from Castanea sativa, inhibited the
growth of Staphylococcus aureus at concentrations up to
128 𝜇g/mL, but, in another study, Sato and coworkers [45]
showed that this same flavonoid isolated from Scutellaria
barbata inhibited the growth of strains of Staphylococcus
aureus at concentrations between 3.9 and 15.6 𝜇g/mL. These
discrepancies could be attributed to the different techniques
employed to evaluate the antimicrobial action of flavonoids,
different solvents used to dissolve the molecules, or the
provenance of flavonoid [29].
Flavonoids are diverse compounds of plants which play
important roles in growth and defense against microorgan-
isms and pests [46]. In fact, the antibacterial activity of
flavonoids is linked to their structure. Li and colleagues
[47] showed that the linking of N-heterocyclic ring to the
A ring of chrysin makes this molecule 16- to 32-fold more
active against Escherichia coli and Staphylococcus aureus than
its parent compound. Several antibacterial mechanisms of
action have been assigned to these compounds. According
to Cushnie and Lamb [29], the possible mechanisms of
action of the flavonoids are as follows: damage in cytoplasmic
membrane, causing pores in membrane or reduction in
fluidity; inhibition of nucleic acid synthesis by the inhi-
bition of the enzyme topoisomerase; inhibition of cellular
metabolism, resulting from inhibition of the enzymeNADH-
cytochrome C reductase; inhibition of cell wall synthesis
caused by D-alanine/D-alanine ligase inhibition; inhibition
of cell membrane synthesis; and aggregation of bacterial
cells. Furthermore, some studies suggest that flavonoids have
multiple mechanisms of action [29, 48, 49].
This study showed that derriobtusone A inhibited biofilm
formation, reducing the biomass and number of viable
cells of Staphylococcus aureus (Figure 3) at concentrations of
250 and 500 𝜇g/mL. Interestingly, although the planktonic
growth of Escherichia coli was only weakly inhibited by
derriobtusone A, the compound did reduce biomass in
various concentrations and did weakly reduce the number
of viable cells. Although several studies have reported on
the antibacterial action of flavonoids, few works describe the
potential antibiofilm activity of these molecules. A synthetic
flavonoid, 3-arylideneflavanone 2C, showed antibacterial
activity against Staphylococcus aureus and inhibited the initial
adhesion of bacteria to abiotic surfaces, resulting in blocking
biofilm formation [50]. Vikram and colleagues [46] showed
that citrus flavonoids were able to reduce the biofilm for-
mation of Vibrio harveyi and Escherichia coli. Using lectins,
Liljemark and colleagues [51] showed that the formation of
cellular aggregates decreased the number of adherent strep-
tococci and, consequently, biofilm formation. Flavonoids
6 BioMed Research International
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Figure 4: Antioxidant activity of derriobtusone A. (a) Scavenging activity of DPPH (%), (b) chelating ability of ferrous ion (%), (c) reducing
power of ferric ions, and (d) 𝛽-carotene bleaching assay (%). ∗𝑃 < 0.05 compared to positive control.
have the ability to aggregate bacterial cells, thereby poten-
tially explaining the antibiofilm activity of derriobtusone A
[29]. Furthermore, an apple flavonoid, phloretin, inhibits
suppressed autoinducer-2 importer genes (lsrACDBF) of
Escherichia coli, suggesting that this compound interferes
with bacterial quorum-sensing (AI-2) signaling. This study
also showed that phloretin reduces fimbria production of
Escherichia coli [52]. Fimbriae are important structures that
influence bacterial adhesion. Thus, the inhibition of fimbria
formation could be a way to decrease biofilm formation [52,
53].
In addition, derriobtusone A showed potential antiox-
idant activity (Figure 4). Plant phenolic compounds, such
flavonoids, have been associated with the health benefits
derived from consuming high levels of fruits and vegetables,
and these effects have been attributed to their antioxidant
activity [54, 55]. According to Narsinghani and colleagues
[56], aurone derivatives have displayed several pharmacolog-
ical activities, including antioxidant activities, and changes in
their structure have been important in the development of
new antioxidant compounds with improved potency and less
toxicity.
In the present study, derriobtusone A demonstrated its
ability to scavenge DPPH radical. Even at the lowest con-
centration tested, the compound displayed over 50% DPPH
activity and also showedmoderate chelating ability of ferrous
ion. These results corroborate those of Narsinghani and
colleagues [56] who showed significant antioxidant activity
for five synthetic aurones, using these same two methods;
however, the synthetic compounds showed a satisfactory
reducing power, a fact not evidenced in this study. Moreover,
the compound showed a high potential for inhibiting 𝛽-
carotene oxidation by protecting it against free radicals
generated during linoleic acid peroxidation, in some concen-
trations with activity similar to that of BHA. It is interesting
to note that both derriobtusone A and BHA are compounds
that exhibit apolar characteristics. Furthermore, according to
Frankel and Meyer [57], antioxidants with apolar properties
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are most important because they are concentrated in the
lipid-water interface, thereby preventing the formation of
lipid radicals and 𝛽-carotene oxidation. Another interesting
observation is that BHA at high concentrations may induce
gastrointestinal hyperplasia [58].
Studies have shown that the antioxidant activity of
flavonoids depends on the arrangement of functional groups
about the nuclear structure [54, 59]. Multiple hydroxyl
groups and their position in the molecule confer upon the
molecule substantial antioxidant, chelating, and prooxidant
activity, while O-methylation can suppress the action of the
compound [60, 61]. Other structural features important for
the antioxidant activity of flavonoids are the presence of
unsaturation in conjugation with a 4-oxo-function in the
C-ring and the presence of functional groups capable of
binding transition metal ions. The lack of these groups in
derriobtusone A may explain the moderate chelating ability
of ferrous ion and ferric-reducing power presented in this
study [62].
The question of flavonoid toxicity has been raised, even
though this compound is widely distributed in edible plants
and beverages [28]. Despite the minimal toxicity in such
plants and beverages, Magalha˜es and colleagues [40] showed
that flavonoids from Lonchocarpus montanus displayed high
toxicity in their brine shrimp lethality assay, including der-
riobtusone A (LD
50
− 1.6 𝜇g/mL). Corroborating this result,
Santos and colleagues [21] showed that the extract from the
root bark of Lonchocarpus filipes and three flavonoids isolated
from this plant displayed high toxicity using the same assay.
Interestingly, derriobtusone A from Lonchocarpus obtusus
was shown to be nontoxic toArtemia sp. nauplii in the present
study.
In summary, derriobtusone A showed potential antibac-
terial activity against Staphylococcus aureus and the ability
to inhibit its biofilm formation. A decrease of Escherichia
coli biofilm biomass was also shown. Furthermore, the com-
pound showed antioxidant potential without toxicity. Thus,
derriobtusone A may be a potential agent against infections
caused by Staphylococcus aureus biofilms, and it may also
have antioxidant properties for possible use against oxidative
stress.
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